Sharing-our-perspective-page-header2

Sharing perspectives leads to greater understanding and fuels innovation. The ​Optum Insights ​blog is where we share our perspective and challenge preconceptions to clear a new path forward



  • New York Workers’ Compensation Board provides additional clarification on mandated drug formulary notifications

    by
    • Optum for Workers' Compensation
    | Aug 15, 2019
    Tag Icon
    Pharmacy, New York, Government Affairs, formulary, Clinical
    The New York State Workers’ Compensation Board (WCB) has released information on how to implement the mandated communications to claimants and their prescribers who will be impacted when the new drug formulary goes into effect in December 2019.


  • AWP price decrease for tizanidine tablets hits the WCMSA portal

    by
    • Medicare Insights
    | Aug 07, 2019
    Tag Icon
    Medicare Insights, medicareinsights blog, AWP
    A new lower price for tizanidine HCL 4 mg tablets is now reflected in the Workers’ Compensation Medicare Set Aside (WCMSA) portal pricing. It was updated August 2, 2019 due to a new lower RED BOOK® Average Wholesale Price (AWP).


  • First generics for Lyrica® arrive to market ― significant savings expected

    by
    • Medicare Insights
    | Aug 06, 2019
    Tag Icon
    Generics, Pain Management, Pharmacy, Medicare Insights, medicareinsights blog, Lyrica
    The Workers’ Compensation Medicare Set Aside (WCMSA) portal has been updated to reflect some of the generic formulations of Lyrica® (updates listed below). We expect to see significant savings with the addition of these generics to the marketplace.


  • New York announces process for payers to access the Drug Formulary Prior Authorization System

    by
    • Optum for Workers' Compensation
    | Aug 06, 2019
    Tag Icon
    Pharmacy, Clinical, Government Affairs, New York, formulary
    The New York State Workers Compensation Board (WCB) has released information on how to access and use the Drug Formulary Prior Authorization System. This is a web-based application to support the new drug formulary. It will be accessible on the WCB website and medical portal.


  • 5 Advanced Ways Clinical Expertise Can Improve Workers’ Comp Outcomes

    by
    • Optum for Workers' Compensation
    | Aug 01, 2019
    Tag Icon
    PBM, Clinical Intervention, Clinical
    Caring for injured workers should involve more than just processing transactions. Applying a clinical approach from the onset of an injury ensures more appropriate care and better outcomes.


  • States continue to approve medical marijuana ―
    could this open the door to use in workers’ comp?

    by
    • Kevin Tribout
    • Adam Fowler
    • Optum for Workers' Compensation
    | Jul 31, 2019
    Tag Icon
    Pharmacy, Pain Management, Workers' Compensation, Clinical, Chronic Pain, Government Affairs, Medical Marijuana
    More and more states are reversing course and expanding support for medical marijuana, even though, not that long ago, these states disapproved of it. Could the groundswell of support among states for medical marijuana open the door to use in workers’ comp? Read more on our blog.


  • FDA approves first alternative medications to Lyrica (pregabalin)

    by
    • Optum for Workers' Compensation
    | Jul 22, 2019
    Tag Icon
    Workers' Compensation, workers compensation, Medicare Insights, Settlement Solutions, Pain Management, Lyrica, Clinical
    Much anticipated alternative medications for Lyrica® (pregabalin) were approved by the U.S. Food and Drug Administration (FDA) on July 19, 2019. This approval follows a six-month delay announced last year. Pregabalin is an anticonvulsant with FDA approval to treat neuropathic (nerve) pain associated with diabetes, postherpetic neuralgia (shingles), fibromyalgia and neuropathic pain associated with spinal cord injury. In addition, it is approved as adjunct therapy for the treatment of partial onset seizures.



Stay informed by receiving latest updates

Do you have a question about a blog post?

See more insights